Pozna 2013/2014 Department of Biochemistry and Molecular Biology Karol Marcinkowski University of Medical Sciences 6 wicickiego St. 60-781 Pozna (Poland) phone (+48 61) 85 46 513, (+48 61) 85 46 519 fax (+48 61) 85 46 510 www.biolmol.ump.edu.pl
Director of the course: Pawe Jagodziski, Ph.D. Head of Department
Lecturer: Pawe Jagodziski, Ph.D. Head of Department pjagodzi@ump.edu.pl
Rules and Regulations for the 6-year M.D Program, Academic Year 2013/2014
OBJECTIVES The main objectives of the course are to provide an understanding of biochemical processes and to gain relevant basic laboratory skills according to the educational requirements defined in the program of teaching biochemistry for medical students.
FORMAT The program (160 h) consists of lectures (40 h), seminars (48 h) and practical classes (72 h). The course is divided into four modules: Proteins, Nucleic Acids, Carbohydrates and Lipids. Each module comprises lectures, introduction and laboratory classes, seminars, clinical correlations and review.
LABORATORY CLASSES Prior to entering the laboratory classes within each module, during introduction classes, a student can take the introductory review to get a bonus points (10 points for each module), comprising biochemical background covering the respective module. The performance during each laboratory class will be evaluated by the quality of theoretical preparation, laboratory skills and a written protocol from the experiments, which must be delivered in less than 3 days, and will be graded from 0 to 5 points (up to 20 points for 4 laboratory classes). For each absence in the class, two points will be subtracted.
SEMINARS AND REVIEWS The performance during seminar classes will be evaluated by partial test, covering the topics of each seminar within the single module (10 one-choice questions, graded 1 point for a correct answers). At the end of each module, the students will be subjected to a closing test during reviews, covering the topics of all seminars and lectures within the module (30 one-choice questions, graded 1 point for a correct answer).
CONDITIONS FOR EARNING CREDIT During the entire course, a student can accumulate jointly for the laboratory classes, seminars and closing tests up to 260 points (100%) plus up to 40 bonus points extra (bonus points will be added to the final score). To receive a credit and be admitted to the final examination, a student must earn a minimum of 182 points (70%). A student, who accumulated from 78 to 181 points (3070%), to receive the credit and be admitted to the final examination, must pass an integrative test (50 questions) during final review, covering topics of the four modules, and get 60% of points. A student, who did not pass the integrative test, is entitled to two retakes, according to the schedule. A student, who accumulated less than 78 points (<30%) is not be allowed to take the integrative test and will not receive a credit for the course. Numbers of the points accumulated during the entire academic year will be converted to a grade, according to the following system:
7074% satisfactory 8084% good >90% very good 7579% fairly good 8589% better than good
FINAL EXAMINATION Students who have earned credit must take the Final Exam. The passing mark and grading system will be set on the basis of the exam scores. If a grade obtained on the Final Exam is lower than grade from entire academic year, the final mark can be upgraded and will be a mean of these two grades. The final mark cannot be upgraded when the student does not pass the Final Exam. If a failing grade is obtained, the final examination can be retaken twice according to the schedule. The passing mark and grading system will be set on the basis of the results of retake exams. THE BIOCHEMISTRY COURSE Rules and Regulations for the 6-year M.D Program, Academic Year 2013/2014
1. Cheating is not allowed. Students who do not obey this rule will be subjected to disciplinary action according to School Regulations on cheating.
2. Students are required to conduct themselves in a professional manner - see School Regulations.
3. Using mobile-phones, mp3, radios and other electronic equipment during classes and exams is not allowed.
4. Eating, drinking, and having any food or beverages during classes is not allowed. Food and drinks will be immediately discarded by the tutors.
5. Filming and other recording of the lectures and seminars is not allowed. Students who do not obey this rule will also be subjected to disciplinary action.
6. Making copies or photos of exams, tests and other quizzes is not allowed.
7. Booking travel ticket is not considered an excuse for missing any compulsory University activity.
8. The student has the right to see each of his/her written papers or answer sheet within 7 working days following the announcement of the results.
9. In cases concerning procedures not included in the present Biochemistry Course Regulations, School Regulations and General School Regulations apply.
I acknowledge that I have read and understood these Biochemistry Course Regulations.
Signed:.
Name (Please print):.
Safety Notes for Students working in Biochemistry Laboratories General Smoking, drinking and eating are forbidden in laboratories. During classes laboratory coats must be worn and each student should have a lab book. Possible hazards 1. Glassware: Always inspect glassware before use for chips and cracks. The most common laboratory accident is cut hands from damaged glassware. 2. Solvents: When handling ether, ethanol, acetone and other organic flammable liquids risk of fire must be considered at all times. When handling corrosive materials such as e.g. sodium hydroxide, concentrated acids or phenol, safety glasses and gloves must be worn. 3. Homogenizers and blenders: Great care should be taken to ensure that the instrument is not switched on in the absence of the appropriate shielded glass container. The instrument must be switched off and the rotating blades at rest before disconnecting the shielded container. 4. Centrifuges: When using centrifuges care should be taken to ensure that the tubes are properly balanced. Check that the rubber cushions are in the tube holders. 5. Electrical apparatus: It is forbidden to disconnect plugs from apparatus, reconnect plugs or replace fuses. If any piece of electrical apparatus appears to be defective, it must be checked by a qualified electrician. 6. Toxic chemicals: All handling of toxic chemicals such as e.g. cyanide, organic solvents etc. should be conducted with great care and when necessary protective gloves should be worn. Pipetting toxic chemicals by mouth is forbidden. Any spillage of toxic chemicals must be cleaned up immediately. 7. Biological hazards: All samples of human blood must be regarded as major biological hazard and handled wearing disposable gloves. When human blood is used automatic pipettes must be employed and the material disposed in the specially designated containers. Laboratory cleanliness: 1. All spillages of liquids and chemicals, especially onto any instrument or piece of equipment must be cleaned up immediately. 2. Bottle stoppers must be replaced immediately after use of the reagent. 3. The weighing must be done in suitable containers. 4. All laboratory ware must be rinsed or washed after use. 5. Bench surfaces must be wiped clean and equipment and bottles arranged tidyly. 6. Biological material must be placed in special containers. 7. Cuvettes must be rinsed after use and returned to their box.
I hereby confirm that I read the safety notes: Name .......................................... Signature ..............................................
Seminar and Laboratory Program
For students of the 6-year M.D. program Academic Year 2013/2014
I. Proteins II. Nucleic Acids Introduction I Introduction II Lab. 1 Plasma proteins
Lab. 2 Preparation and restriction analysis of plasmid DNA Sem. I Structure and functions of proteins Sem. II Haemoglobin Sem. III Enzymes Sem. IV DNA structure and replication Sem. V DNA transcription. RNA structure and function Sem. VI Protein biosynthesis Sem. CC-I Clinical correlations I Review I
Sem. CC-II Clinical correlations II Review II III. Carbohydrates IV. Lipids Introduction III Introduction IV Lab. 3 Blood glucose Lab. 4 Properties and analysis of lipids Sem. VII Metabolism of monosaccharides Sem. VIII Metabolism of polysaccharides Sem. IX Glucose homeostasis in humans Sem. X Metabolism of fatty acids Sem. XI Biosynthesis and degradation of lipids Sem. XII Interorgan transport of lipids Sem. CC-III Clinical correlations III Review III Sem. CC-IV Clinical correlations IV Review IV
PROTEINS
P R O T E I N S
INTRODUCTION I
LABORATORY
Laboratory 1. Plasma proteins
SEMINARS
Seminar I. Structure and functions of proteins
Seminar II. Haemoglobin
Seminar III. Enzymes
Seminar CC-I Clinical correlations I
REVIEW I INTRODUCTION TOPICS
PROTEINS
Structure of amino acids (structural formulas). Classification of amino acids based on: structure of side-chain groups, essential and nonessential amino acids, apolar and polar amino acids, glucogenic and ketogenic amino acids. Properties of amino acids: isoelectric pH (pI), isomers, formation of peptide bonds. Biologically active peptides: carnosine, anserine, glutathione, oxytocin, vasopressin and bradykinin. Structure and properties of proteins based on: amino acids contents, shape of protein molecules, solubility in water, function. Conformation of proteins: bonds stabilising protein structures, precipitation of proteins (dehydration and denaturation). Enzymes: nomenclature, classification, specificity, classification and function of some coenzymes.
TEXTBOOK AND READING
Harpers Illustrated Biochemistry 27 th edition Murray R. K. et al. Lange Medical Books/McGraw-Hill, 2006 ISBN: 0-07-147885-x
Harpers Illustrated Biochemistry 28 th edition Murray R. K. et al. Lange Medical Books/McGraw-Hill, 2009 ISBN: 978-0-07-162591-7
Biochemistry 6 th edition J. M. Berg, J.L. Tymoczko, L. Stryer W.H. Freeman, 2006 ISBN: 0716787245
Textbook of Biochemistry 6 th edition Devlin T. M. Wiley, 2006 ISBN: 0-470-10989-0 LABORATORY 1 Plasma proteins TOPICS Structure, properties and functions of plasma proteins. Separation of plasma proteins by electrophoresis. Determination of protein concentration by spectrophotometric method.
ELECTROPHORESIS OF SERUM PROTEINS IN AGAROSE GEL
Principles: The electrophoretic separation can be achieved in buffer solutions of pH far from isoelectric point of the protein (free electrophoresis), or with the aid of solid support, such as cellulose, agarose or polyacrylamide gels. The speed of migration of the molecules depends on voltage differences, and the charge and shape of the molecules. Electrophoresis can be used for the separation of serum proteins. We can detect the following fractions of serum proteins: albumins, 1 , 2 , and -globulins.
Materials: Electrophoretic apparatus with water thermostated cell, Pt electrodes, plastic comb, power supply, trays for staining and fixing gel. Agarose, electrophoretic grade. Electrophoresis buffer: 10 times concentrated Tris-borate EDTA pH 8.0 (10x TBE) Indicator solution: 1% bromophenol blue Fixing solution: 10% sulfosalicylic acid (w/v) and 40% ethanol (v/v) in water Staining solution: (must be prepared immediately before use) A. 2% phosphoric acid (w/v), 0.1% Coomassie-R-250, 6% (NH 4 ) 2 SO 4 (w/v), 25% ethanol (v/v) B. 5% Coomassie-R-250 (w/v) C. 20% ethanol (v/v) D. 96% ethanol (v/v)
Method: 1. Casting the gel: weigh out 1 g of agarose and transfer it into a conical flask. Add 100 ml of ten times diluted TBE buffer (1x TBE), bring to boiling in a microwave to dissolve. Cool solution to about 50C. Insert a comb and pour the agarose into a casting tray. Allow the agarose to solidify and carefully remove the comb. 2. Sample application: fill the chamber with the buffer to about 5 mm above the gel surface. Prepare samples by mixing equal volumes (e.g. 50 l) of serum and 50% sucrose solution. Add 510 l of 1% bromophenol blue to 100 l of serum/sucrose solution and use this sample as marker. This dye will make the albumin fraction visible during the run. Other samples will be run without the dye. Apply 50 l of serum sample to separate wells. 3. Electrophoresis: connect the electrodes and turn the power supply on. The electrophoresis is carried out at 20 V/cm of the gels length, or as long as the blue-stained albumin fraction migrates about 5.5 cm (takes 45-60 min.). Turn the power supply off. 4. Fixing of gel: remove gently the gel from the chamber and insert it in the tray. Keep the tray with gel for 10 min in fixing solution mixing from time to time. 5. Wash the gel two times for 5 min in 50 ml 20% ethanol (solution C). 6. Staining: add 98 ml solution A, 2 ml solution B and 25 ml 96% ethanol (solution D) to conical flask (300 ml capacity). Mix vigorously to prepare colloidal solution. Cover the gel by the above solution and mix gently for 30 min. To remove excess of the dye, wash the gel three times in distilled water. Analyse the visible bands of proteins.
SPECTROPHOTOMETRIC DETERMINATION OF TOTAL PROTEIN CONCENTRATION IN SERUM BY USING THE BIURET METHOD.
Principles: Proteins and peptides that have more than one peptide bond in their structure, produces purple colour complex with copper (II) ions in an alkaline solution (so called biuret reaction). To avoid precipitation of Cu(OH) 2 under alkaline conditions, copper ions are chelated by sodium potassium tartrate.
Materials: 0.9% solution of NaCl Biuret reagent: 5 g CuSO 4 x 5H 2 O in alkaline solution with potassium sodium tartrate (45 g potassium sodium tartrate plus 5 g potassium iodide in 1000 ml 0.2 M NaOH).
Method: 1. Preparation of standard curve: standard curve is the plot of absorbancy versus the protein concentration. To prepare standard curve, we use serum solution of known protein concentration. Standard serum contains 7.2 g protein per 100 ml. 2. Preparation of standard protein solutions: dilute the standard solution of serum in 50 ml conical flask with 0.9% NaCl according to the table below:
Number of conical flask (50 ml) 1 2 3 4 5 6 7 Volume of standard serum (ml) 0.50 0.75 1.00 1.25 1.50 2.00 2.50 Protein concentration (g/100 ml) 0.072 0.108 0.144 0.18 0.216 0.288 0.36
Fill up the conical flask to 50 ml using 0,9% solution of NaCl. Simultaneously prepare samples of unknown concentration according to point 5. 3. Colour reaction: prepare two rows of tubes (7 tubes in each row) and one control tube. Using the pipette, transfer 5 ml of each standard serum solution to parallel tubes. Add 5 ml of 0.9% NaCl solution to last tube (control sample), then add 5 ml of biuret reagent to each sample. Mix well the tubes and keep 30 min at room temp. Measure the absorbancy of each sample against the blank at 570 nm wavelength. Note: do not remove the blank, and keep it for determination of serum protein concentration in all samples. 4. Calculation and the presentation of results: calculate mean absorbancy of parallel samples. Draw the absorbancy (on the ordinate) versus protein concentration (on the abscissa). The standard curve should be a straight line. Calculate the coefficient by dividing the value of the concentration of the protein by the absorbancy. 5. Determination of protein concentration in serum: pipette 0.15 ml of serum of unknown protein concentration to three tubes (2-4), use tube 1 as a blank. Add the biuret reagents to samples according to the table below:
6. Mix well and keep 30 min at room temp. Measure the absorbancy at 570 nm. Calculate mean absorbancy of parallel samples. Read protein concentration from the standard curve. Calculate final protein concentration using the following formulas:
C = F x A x D
C = D x c
Where: C final protein concentration; F coefficient; A absorbancy; D dilution of the sample; c protein concentration of sample read from the standard curve.
Draw conclusions from the results.
SEMINAR I Structure and function of proteins 1. The structure of polypeptide chain.
2. Levels of protein organisation: a. primary, secondary, tertiary, quaternary structure b. domains of protein c. -helix, -sheet d. triple helix of collagen type I
3. Relationship between amino acid sequence and conformation of a protein.
4. Techniques of protein separation and detection.
5. Biological relevance and function of proteins.
6. Plasma proteins: a. constituents of plasma proteins b. role of albumin in the maintenance of osmotic pressure and the binding of various ligands c. transport function of globulins d. role of haptoglobin in haemoglobin binding e. participation of transferrin and ceruloplasmin in iron and copper metabolism f. role of fibrinogen in blood clotting g. properties of human immunoglobulins h. acute phase proteins i. disorders in plasma protein contents Wilsons disease and 1 -antitrypsin deficiency
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 14-40, 588-605. Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 31-42, 566-582. Stryer L. Biochemistry 6 th edition pp. 25-64. Devlin T. M. Textbook of Biochemistry 6 th edition pp. 75-132, 320-327
SEMINAR II Haemoglobin 1. Haemoglobin as an allosteric protein: a. conformation of haemoglobin molecules, bonds stabilising its structure b. myoglobin structure c. normal haemoglobin
2. Participation of haemoglobin in oxygen and carbon dioxide transport: a. haemoglobin and myoglobin oxygen affinity curves b. influence of allosteric effectors on haemoglobin and myoglobin affinity to oxygen (2,3- bisphosphoglycerate, CO 2 , pH, homotropic and heterotropic effects)
3. Conformation changes accompanying oxidation of haemoglobin.
4. Mechanism of carbon dioxide transport from peripheral tissues to lungs: a. role carbonic anhydrase
5. Haeme biosynthesis and regulation: a. disorders in globulins synthesis b. pathological haemoglobin (thalassemias, HbS, HbM, HbC) and mechanism of haemo- globinopathies c. porphyrias
6. Hem catabolism and releasing of hem metabolites: a. bilirubin synthesis b. plasma bilirubin transport c. mechanism of bilirubin binding in liver and releasing complex haemoglobin with bile pigments d. conversion of bilirubin in the intestine e. intestine-liver circulation of bile pigments f. jaundice
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 41-48, 279-293. Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 43-50, 271-284. Stryer L. Biochemistry 6 th edition pp. 183-204 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 338-351, 833-844 SEMINAR III Enzymes 1. Structure of enzymes: catalytic site, substrate binding site, allosteric site, multifunction enzymes and enzymatic complexes, prosthetic group, cofactors.
2. Classification of enzymes.
3. Kinetics of enzymatic reaction: a. relation between substrate concentration and reaction velocity Michaelis-Menten equation b. linear form of the Michaelis-Menten equation Lineweaver-Burk plot. Hills equation c. influence of temperature, pH and enzyme concentration on reaction velocity
4. Activators and inhibitors of enzymes, role of metal ions, competitive and non-competitive reversible and irreversible inhibitors.
5. Methods of enzyme activity determination, units of enzyme activity.
6. Regulation of enzymatic activity by allosteric or covalent modification.
7. Intracellular compartmentalisation of enzymes.
8. Clinical applications of enzymes: isoenzymes, secretary enzymes and disease indicator enzymes.
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 49-81 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 51-83 Stryer L. Biochemistry pp. 205-302 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 328-337, 365-412
NUCLEIC ACIDS
N U C L E I C A C I D S
INTRODUCTION II
LABORATORY
Laboratory 2. Preparation and restriction analysis of plasmid DNA
SEMINARS
Seminar IV. DNA structure and replication
Seminar V. RNA structure and function. DNA transcription.
Seminar VI. Protein biosynthesis
Seminar CC-II Clinical correlations II
REVIEW II INTRODUCTION TOPICS
NUCLEIC ACIDS
Chemical formulas and nomenclature of purine and pyrimidine nucleotides. Nucleosides and nucleosidomono-, di- and triphoshates. Nucleosides (S- adenosylmethionine) and (nucleotides, NMN, NAD, NADP, FMN, FAD, CoA, PAPS) as coenzymes. Deoxyribonuleic acid: structure of single strand, double helix, higher order structures, denaturation and renaturation of DNA (melting temperature, hiper and hipochromic effects). Ribonuleic acids (rRNA; tRNA; mRNA; snRNA) structure and function. Hydrolysis of nucleic acids: (a) acid hydrolysis of DNA and RNA (b) alkaline hydrolysis of RNA (c) products of hydrolysis (d) enzymatic hydrolysis of DNA and RNA: endo- and exonucleases, restriction enzymes.
LABORATORY 2 Preparation and restriction analysis of plasmid DNA PREPARATION OF PLASMID DNA
Adapted from Sambrook J. et al., Molecular Cloning. A laboratory Manual 1.21-1.31, Cold Spring Harbour Laboratory Press, 1989.
A. Harvesting of bacteria Method: 1. Transfer a single bacterial colony into 2 ml of LB medium containing the appropriate antibiotic in loosely capped 15 ml tube. Incubate the culture overnight at 37C with vigorous shaking. LB medium To 950 ml of deionized water add: yeast extract 5 g, NaCl 10 g and dissolve. Adjust pH to 7.0 with 5N NaOH. Make up to 1 L with deionized water. Sterilise by autoclaving. 2. Pour 1.5 ml of culture into a microfuge tube. Centrifuge at 12 000 g for 30 sec. at 4C. 3. Remove the medium by aspiration, leaving pellet as dry as possible. Note: the bacterial pellet will be prepared by an instructor.
B. Lysis by alkali Method: 1. Resuspend the bacterial pellet in 100 l of ice-cold Solution I by vigorous vortexing (the technique will be demonstrated by an instructor). Solution I 50 mM glucose 25 mM Tris HCl pH 8.0 10 mM EDTA pH 8.0 Question: What happens at this step? Why is it recommended not to vortex the contents of the tube? 2. Add 200 l of freshly prepared Solution II. Close the tube tightly and mix the contents by inverting the tube rapidly five times. Do not vortex. Store the tube on ice. Solution II 0.2N NaOH (diluted from a 10N stock) 1% sodium dodecyl sulphate (SDS) 3. Add 150 l of Solution III. Close the tube and vortex it gently in an inverted position for 10 sec. to disperse the viscous bacterial lysate. Store the tube on ice for 35 min. Solution III 5 M potassium acetate 60.0 ml glacial acetic acid 11.5 ml water 28.5 ml The solution is 3 M with respect to potassium and 5 M with respect to acetate. Question: Why is bacterial lysate viscous? Why is it recommended to vortex gently in an inverted position? 4. Centrifuge at 12 000 g for 5 min. at 4C. Transfer the supernatant to a fresh tube. Question: What compounds were left in the pellet? What compounds are in the supernatant? 5. Precipitate the double-stranded DNA with 2 vol of 95% ethanol at room temperature. Mix by vortexing. Leave on bench for 2 min. Question: Why can DNA be precipitated with absolute ethanol? Does RNA co-precipitate with DNA? 6. Centrifuge at 12 000 g for 5 min in a microfuge. 7. Remove the supernatant by gentle aspiration (will be demonstrated by an instructor). Leave the tube in an inverted position on a paper towel to drain away the fluid. Remove any drops adhering to the walls. 8. Rinse the pellet with 1 ml of 70% ethanol at 4 C. Remove the supernatant and allow the pellet to dry in air for 10 min. Question: Why 70% ethanol is used for rinsing the pellet? 9. Redissolve the pellet in 20 l of TE buffer pH 8.0 containing DNase-free pancreatic RNase (20 mg/ml). Tris EDTA buffer (TE) 10 mM Tris HCl pH 8.0 1 mM EDTA pH 8.0 Questions: What is the role of EDTA in the buffer? Why is it recommended to add RNase to the DNA preparation? Note: the usual yield is about 35 l DNA/ml of culture.
RESTRICTION ANALYSIS OF PLASMID DNA
Adapted from Sambrook J. et al., Molecular Cloning. A laboratory Manual 1.21-1.31, Cold Spring Harbour Laboratory Press, 1989.
A. Digestion of DNA with restriction enzymes Method: 1. To analyse the DNA by cleavage with restriction enzymes to 20 l of the DNA prep add: 2 l of the buffer R 0,5 l restriction enzyme Xho I 0,5 l restriction enzyme Hind III mix by tapping the tube Note: restriction enzymes will be added by an instructor 2. Incubate the reaction mixture for 1 h at 37C. Question: What happens during the incubation? 3. Analyse the DNA fragments of the restriction digest by agarose gel electrophoresis.
B. Preparation of agarose gel Method: 1. Seal the open ends of the plastic tray within the electrophoresis apparatus as to form a mold. 2. Add 1 g of agarose to 100 ml of 0.5x TBE buffer (containing 10 ml of 5x TBE buffer and 90 ml of deionized water). Heat the slurry in a microwave until the agarose dissolves. 5x Tris-borate-EDTA buffer: Tris base 54.0 g boric acid 27.5 g 0.5 M EDTA pH 8.0 20 ml dissolve in 1 L of deionized water 3. Cool the solution to 60C, add ethidium bromide (EtBr) to a final concentration of 0.5 mg/ml, mix thoroughly. Ethidium bromide stock solution: Dissolve 10 mg of EtBr in 1 ml of water, store in light-tight container (will be provided by an instructor). Caution: Ethidium bromide is a mutagen. Gloves should be worn when handling EtBr. 4. Position the comb 0.5-10 mm above the plate so that a well is formed when agarose is poured. 5. Pour the warm agarose solution into the mould, let the gel set for 30 min. During this time dilute 10-fold the TBE 5x buffer pH 8.0 with deionized water. 6. Carefully remove the comb, mount the gel in electrophoresis tank and add diluted buffer to cover the gel to a depth of about 1 mm.
C. Agarose gel electrophoresis Method: 1. Mix 5 volume of the sample with 1 volume of the 6x gel-loading buffer. Slowly load the samples into the slots using a micropipette and a yellow tip (it will be demonstrated by an instructor). The sample containing molecular size markers will also be loaded. Gel loading buffer (6x): Bromophenol blue 0.25% Xylene cyanol FF 0.25% Ficol type 400 0.15% Question: Why is it recommended to add gel loading buffer? What is the advantage of running the molecular size markers? 2. Cover the tank with the lid and attach the electrical leads so that DNA will migrate towards the anode (+). Apply the voltage of 1-5 V/cm (measured from kathode to anode). Run until the bromophenol blue has migrated about 2/3 of the distance of the gel. Question: Why does DNA migrate towards the anode? What is the principle of separation of DNA fragments? 3. Turn off the current, open the lid and carefully remove the tray with the gel. Examine the gel under UV light to detect the insert that was cut out with restriction enzymes. Take a photograph with a polaroid camera (will be demonstrated by an instructor). Caution: UV light can damage your eyes and skin. Always wear protective goggles. Note: the minimum amount of DNA that can be detected by photography (it is more sensitive than your eyes!) in about 2 ng in 0.5 cm wide band. If there is more than 500 ng in a single band, trailing and smearing appears. However, if bands are numerous it is possible to load over 10 mg per slot without significant loss of resolution. Question: What is the significance of DNA analysis in medicine?
SEMINAR IV DNA structure and replication 1. Primary structure of DNA: a. phosphodiester bond b. hydrogen bonds c. single copy, moderately and highly reiterated sequences
2. Secondary structure of DNA: a. periodic structures b. forces that determine polynucleotide conformation c. double helix d. various geometric and renaturation parameters of the DNA double helix e. denaturation and renaturation of DNA (hybridisation, probes, heteroduplexes) f. topology of DNA molecules (linear, circular, relaxed and supercoiled DNA) g. the nucleotide sequence of the human genome h. function of histones in DNA packaging
3. DNA replication in Prokaryotes and Eukaryotes: a. semiconservative mechanism of replication b. substrates for DNA replication c. role of template DNA d. enzymes involved in replication (DNA polymerases, topoisomerases, ligase) e. other proteins involved in replication f. synthesis of primer for replication g. chain elongation h. control of DNA replication
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 311-314, 322-342 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 302-305, 312-330 Stryer L. Biochemistry 6 th edition pp. 107-118, 783-804 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 23-61, 133-152 SEMINAR V RNA structure and function. DNA transcription. 1. Structure of RNA: a. primary b. secondary c. tertiary d. modified nucleotides found in tRNA
2. Characteristics of different types of cellular RNAs: a. mRNA b. rRNAs c. tRNAs d. snRNAs
3. Mechanisms of transcription in Prokaryotes and Eukaryotes: a. substrates for DNA transcription b. role of template DNA (the structure of promoters and enhancers/silencers) c. enzymes involved in transcription (properties of RNA polymerases) d. protein factors involved in transcription (trans elements) e. response elements (cis elements) f. initiation of transcription g. chain elongation h. termination i. regulation of gene transcription
4. Post-transcriptional processing of RNA: a. 45S rRNA (role of RNases) b. hnRNA (capping, addition of poly-A tail, splicing) c. tRNA (cleavage, additions, modification of nucleotides)
5. Clinical correlations: a. inhibitors of Prokaryotic RNA polymerase b. inhibitors of Eukaryotic RNA polymerases c. involvement of transcription factors in carcinogenesis
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 314-321, 348-364, 380-401 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 305-311, 335-352, 369-387 Stryer L. Biochemistry 6 th edition pp. 118-131, 821-856 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 62-70, 175-195, 291-318 SEMINAR VI Protein biosynthesis 1. Components of the translation apparatus: a. mRNA as carrier of information (genetic code) b. structure and role of ribosomes c. tRNA as an adaptor molecule (amino acid activation and aminoacylation of tRNA)
2. Initiation of translation in Prokaryotes and Eukaryotes: a. initiation codon b. initiating amino acid (formylation of methionine) c. sequence of events in the initiation process d. role of initiation factors e. regulation of initiation f. antibiotics-inhibitors of chain initiation
3. Elongation of the polypeptide chain: a. elongation process in Prokaryotes b. elongation process in Eukaryotes c. peptidyl transferase d. antibiotics-inhibitors of elongation
4. Termination of translation: a. termination codons
5. Post-translational modification of proteins: a. glycosylation b. phosphorylation c. mitochondrial proteolytic processing
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 365-379 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 353-368 Stryer L. Biochemistry 6 th edition pp. 857-891 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 201-244
CARBOHYDRATES
C A R B O H Y D R A T E S
INTRODUCTION III
LABORATORY
Laboratory 3. Blood glucose
SEMINARS
Seminar VII. Metabolism of monosaccharides
Seminar VIII. Metabolism of monosaccharides and polysaccharides
Seminar IX. Glucose homeostasis in humans
Seminar CC-III Clinical correlations III
REVIEW III INTRODUCTION TOPICS
CARBOHYDRATES
Classification and nomenclature of carbohydrates. Isomerism of carbohydrates. Structural formulas of most common monosaccharides. Physical and chemical properties of carbohydrates (solubility, optical properties, oxidation and reduction products). Biologically important derivatives of monosaccharides (deoxy-, amino- sugars, phosphate esters). Glycosidic bonds. Structure and function of oligo- and polysaccharides (disaccharides, starch, glycogen, cellulose). Glucosaminoglycans and glycoproteins.
LABORATORY 3 Blood glucose ENZYMATIC DETERMINATION OF BLOOD GLUCOSE BY MEANS OF A BACTERIAL ENZYME: GLUCOSE OXIDASE
Principle: The aldehyde group of -D-glucose is oxidised by glucose oxidase to gluconic acid and hydrogen peroxide. The intermediate compound is D-glucono-1,5-lactone (GO). Peroxidase (PO) and 4-amino-antypyrine are present in the reaction mixture, so that oxygen is liberated from the hydrogen peroxide and reacts with the 4-amino-antypyrine to produce changes in the intensity of the pink colour. The amount of formed dye is a measure of the glucose that has been oxidised.
Method: 1. Add 0.5 ml of TCA and 50 L of blood into the centrifuge tube. 2. Mix the contents thoroughly. 3. Centrifuge the tubes for 15 min. at 3000 rpm. 4. Add 0.5 mL of 5% TCA and 50 L of glucose standard into the centrifuge tube. 5. Mix the contents thoroughly. 6. Label the tubes with 1, 2, 3.
7. Prepare solutions as shown in the table: unknown sample 1 standard sample 2 control sample 3 supernatant 50 L glucose standard 50 L Water 50 L Solution 1 mL 1 mL 1 mL 8. Mix the contents of tubes and incubate at room temperature for 20 min. 9. Read the absorbancy (A) for unknown and standard sample against control sample at 500 nm. 10.Calculate test values as follows: A test
Plasma glucose [mg/dl] = x 100 A standard
DETERMINATION OF THE AMYLASE ACTIVITY IN THE BLOOD PLASMA
Principle: Starch and amylodextrins molecule containing more than 30 glucose residues turn the iodine solution to blue. Amylase hydrolytic activity causes the appearance of the shorten dextrin molecules which do not generate blue colour with iodine solution. Decrease in blue colour intensity corresponds to the amylase activity.
Method: 1. Prepare 4 glass tubes. Add 1 mL of starch substrate to each tube and incubate samples 5 min in 37C. 2. Add 20 L of blood plasma to tubes 1, 2 and 3. 3. Add 20 L of water to tube 4 (control sample). 4. Stop the reactions exactly after 7 minutes 30 seconds by adding 1 mL of iodine solution to each sample and mix vigorously. 5. Add 5 mL of water to each tube and mix. 6. Measure the sample absorbance at the wavelength 660 nm referring to distilled water. 7. Calculate the amylase activity according to formula:
A control A sample Units of enzymatic activity (U)/100 mL of blood plasma = 800 A control
A control absorbance of sample numbered 4 A sample calculated mean absorbance of sample numbered 1, 2 and 3
The one unit of amylase activity is defined as the amount of the enzyme hydrolysing 10 mg of starch in 30 minutes at room temperature to the stage which is not detected by iodine solution. In this method, 1mL of starch substrate containing 0.4 mg of starch is incubated with 0.02 mL of blood plasma for 7 minutes and 30 second at room temperature. It corresponds to 8000 mg of starch incubated with 100 mL of blood plasma for 30 minutes. Hydrolysis of starch 8000 mg is completed by 800 U of amylase present in 100 mL of blood plasma. SEMINAR VII Metabolism of monosaccharides 1. Digestion of carbohydrates: a. sites and enzymes involved in carbohydrate digestion b. deficiencies of intestinal disaccharidases (lactase, isomaltase-sucrase) c. intestinal absorption of monosaccharides (simple diffusion, facilitated transport, active transport)
2. Glycolysis and gluconeogenesis.
3. Pentose phosphate pathway.
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 151-158, 167-180, 482-483 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 149-156, 165-177, 459-460 Stryer L. Biochemistry 6 th edition pp. 433-474, 577-591 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 581-617, 637-642, 1056-1058
SEMINAR VIII Metabolism of monosaccharides and polysaccharides 1. Fructose metabolism
2. Galactose metabolism
3. Disorders of fructose and galactose metabolism
4. Glycogen metabolism: a. glycogen storage diseases
5. Biosynthesis of glucuronic acid
6. Biosynthesis of aminosugars
7. Biosynthesis of complex carbohydrates: a. glycoproteins b. proteoglycans
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 159-166, 180-186, 523-544, 551-558 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 157-164, 177-183, 506-526, 533-539 Stryer L. Biochemistry 6 th edition pp. 312-323, 449-452, 592-616 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 618-636, 643-658 SEMINAR IX Glucose homeostasis in humans 1. Concentration of glucose in blood (hypo and hyperglycaemia)
2. Sources of glucose in blood
3. Control of blood glucose concentration: a. hormonal regulation of glucose levels in blood (including insulin synthesis and degradation as a regulatory means, glucagon, epinephrine, glucocorticoids and other hormones involved in carbohydrate metabolism) b. hepatic control of blood glucose levels (glucokinase, regulatory enzymes of glycolysis, glycogenesis and glycogenolysis, regulation of gluconeogenesis) c. other tissues involved in regulation of blood glucose concentration: muscles (Cori and alanine cycles) kidney (renal treshold for glucose)
4. Overview of glycogen metabolism in liver and muscle
5. Diabetes
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 167-176 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 165-173 Stryer L. Biochemistry 6 th edition pp. 458-474 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 608-636, 863-886
LIPIDS
L I P I D S
INTRODUCTION IV
LABORATORY
Laboratory 4. Properties and analysis of lipids
SEMINARS
Seminar X. Metabolism of fatty acids
Seminar XI. Biosynthesis and degradation of lipids
Seminar XII. Interorgan transport of lipids
Seminar CC-IV Clinical correlations IV
REVIEW IV INTRODUCTION TOPICS
LIPIDS
Classification and nomenclature of lipids (simple lipids, complex lipids). Major components of lipids: fatty acids, alcohols (glycerol, sphingol, inositol, cholesterol), phosphates, organic bases, carbohydrates. Nomenclature of saturated and unsaturated fatty acids. Physical and chemical properties of simple and complex lipids. Digestion and absorption of lipids from the intestine. Forms of lipid transport in blood. Principle sites of lipid synthesis and degradation. Role of lipids as structural components of the cell. Bile composition and role in lipid digestion.
LABORATORY 4 Properties and analysis of lipids ISOLATION AND SEPARATION OF PLASMA AND EGG YOLK LIPIDS
Principle: Lipids in hydrophobic, associated form may be extracted with relatively non-polar solvents, such as ethyl ether, chloroform or petrol-ether. Membrane associated or complex lipids however, require polar solvents, such as ethanol or methanol to disrupt the hydrogen bonding or electrostatic forces between lipids and proteins. Covalently bound lipids, by contrast, cannot be extracted directly by any solvent, but must first be cleaved from the complex by acid or alkaline hydrolysis. Another factor, which must also be considered, is enzymatic degradation of lipids during the extraction process. In general, the use of alcohol containing solvent mixtures is sufficient to inactivate most lipases and phosphatidases. With more stable enzymes, immersion of the extraction mixture for 12 min. in a boiling water bath will usually inactivate them and also enhance precipitation of the denatured protein. From the above considerations, it follows that alcohol is an essential component of the extracting solvent and is required for disruption of lipid-protein complexes, dissolution of the lipids, inactivation of the degradative enzymes, as well as for the precipitation of the denatured proteins and mixing with the aqueous phase. However, there is a drawback introduced by the use of alcoholic solvents for lipid extraction, namely, the co-extraction of contaminants such as sugars, amino acids, salts etc. It is therefore essential, that the crude lipid extract obtained be treated to remove these water-soluble contaminants. The most commonly used procedures are either to wash the primary extract with water, or to evaporate the solvent (preferably under low pressure or in a stream of nitrogen) together with the water, and then to dry residue with a non-polar solvent, to separate water soluble contaminations. Thus obtained lipid mixture may then be further separated, using various methods into individual lipid classes, which can be then identified.
EXTRACTION OF PLASMA LIPIDS
Method: Take a graduated, glass-stoppered test tube and fill it with 9.5 ml of Bloors mixture (ethyl alcohol:ethyl ether 3:1 v/v), then add to this (dropwise) 0.5 ml of blood plasma. Stopper the tube, mix the contents gently and open the tube again. Next, heat the contents on a hot water bath for about 1 min. with constant swirling of the tube. Decant the supernatant into an evaporation dish and evaporate the solvent to dryness on a water bath. Cool down the dish with its contents. Re-extract the dry residue with about 1 ml of hexane and transfer the re-extracted lipids into a small vial. Stopper the vial and preserve the extract for separation by means of TLC (thin layer chromatography).
EXTRACTION OF EGG YOLK LIPIDS
Method: Take one half of a chicken egg yolk and place it in a beaker, extract the lipids with an approximately 20-fold volume of Bloors mixture under occasional stirring for about 10 min. After the denatured proteins have sedimented, decant the supernatant into an evaporation dish and evaporate the solvent to dryness on a boiling water bath. Cool down the dish with its contents (the dry residue contains the total lipids of the egg-yolk).
A. Separation of the neutral lipid fraction from polar lipids Principle: Neutral lipids are readily solubilised by cold acetone, while polar ones are acetone insoluble. By taking advantage of this difference, it is possible to separate these lipids from each other. The so obtained sediment comprises the acetone insoluble lipid fraction and those in solution the neutral lipid fraction.
Method: Extract the residue obtained in the preceding procedure with cold acetone (about 10 ml) and decant the supernatant from the sediment into another evaporation dish. Evaporate the solvent and dissolve the residue in about 3 ml of hexane (petroleum ether). Transfer the solution into a vial and keep for further experiments (separation by means of TLC). Transfer a small lump of this fraction into a small vial, dissolve in about 2 ml of petroleum ether, stopper the vial and keep for further experiments (TLC separation).
PHYSICOCHEMICAL PROPERTIES OF COMPOUND LIPIDS
A. Solubility; demonstration of the amphipathic nature of compound lipids Method: With the aid of a glass rod, transfer small lumps of the acetone insoluble lipids onto the bottom of 3 dry test tubes, number them and add: 5 ml of water into tube 1, 5 ml of ethanol into tube 2 and 5 ml of chloroform into tube 3. Shake vigorously the contents and observe the results. Compare the results of this experiment with those obtained in a similar experiment in which vegetable oil was used (I.). Draw conclusions. Draw an image of the structure acquired by these lipids when solubilised in water.
B. Detergent properties of the water solution of compound lipids Method: Add one drop of vegetable oil to tube 1 from the former experiment, shake vigorously and observe the result. Draw appropriate conclusions. Draw an image of the mixed micelles formed under these circumstances.
C. Demonstration of nitrogen bases Principle: Strong alkali acting at high temperature are capable of hydrolysing ester bonds formed between the nitrogen containing alcohols (serine, ethanolamine and choline) and to decompose these alcoholamines into free volatile aliphatic amines and ammonia. These amines, as well as the ammonia, may be detected both by their characteristic smell and by their alkaline reaction, which may be evidenced with the aid of suitable indicators.
Method: (Will-Varrentrap) The experiment should be done under the fume hood. Place a small lump of the acetone insoluble lipid fraction onto the bottom of a test tube, add a few crystals of soda lime [NaOH-Ca(OH) 2 ], and heat the contents with a lighter till dense fumes will form. Place a damp indicator paper onto the outlet of the tube. You will soon discover the characteristic smell and the indicator paper will change its colour indicating the alkaline character of these fumes. Question: Present the formulas of nitrogen bases present in phospholipids.
D. Test for glycolipids Principle: Sugars, when treated with concentrated sulphuric acid are transformed into cyclic aldehydes (furfural or oxymethylene-furfural) which under anhydrous conditions form coloured condensation products with aromatic phenols or amines (Molishs method).
Method: The experiment should be done under the hood. Heat the contents of tube 2 from the experiment on solubility of compound lipids (alcohol solution) on a water bath heated to boiling temp., add to it 23 drops of -naphtol. Blend the contents and then add carefully after tipping of the tube, 1 ml of conc. sulphuric acid, along the tube wall. Observe the appearance at the contact surface of these two liquids a purple coloured ring. A positive reaction is indicative of the presence of glycolipids in the tested lipid sample. Questions: Give a concise description of the individual glycolipid classes and of their carbohydrate moieties. What can be inferred from all the performed experiments with the acetone insoluble lipid fraction?
SEPARATION OF EGG YOLK AND PLASMA LIPIDS BY MEANS OF THIN- LAYER CHROMATOGRAPHY (TLC)
Principle: Having extracted and partially analysed the tissue or cellular lipids (as described above) one has some idea of the classes of compounds present in the mixture. The next stage of investigation of lipid composition involves fractionation of the mixture into various classes of lipids and then into pure individual components. The exact fractionation procedure to be used at this stage will depend largely on the particular classes of lipids present. These methods may include: solvent fractionation (as in the acetone precipitation of compound lipids); solvent partition (counter-current distribution), column-adsorption, partition- and ion-exchange chromatography, surface chromatography on silic acid-impregnated paper or thin-layer chromatography (TLC).
Method: The lipid mixtures to be separated are: a. plasma total lipids b. acetone soluble lipid fraction from egg-yolk
A. Preparation and conditioning of chromatographic chambers Method: Chamber N (neutral lipids) Chromatographic solvent: hexane : diethyl ether : acetic acid, (84 : 16 : 0.8 V/V). Pour the solvent into the separation chamber, just enough to cover the bottom of the jar and screw tightly the lid onto the opening of the jar. Leave enough time to saturate the chamber with solvent vapors (not less than 15 min.). Chamber P (polar lipids) Chromatographic solvent: chloroform : methanol : water (65 : 25 : 4 V/V). Proceed as described for chamber N except that solvent P has to be used.
B. Application of lipid extracts onto pre-coated TLC micro-slides Into a Hamilton-micro-syringe dispenser aspirate 100 l of the respective lipid extract (acetone soluble, acetone insoluble lipids of egg-yolk and the total plasma lipids). Spot the lipid extract drop by drop onto the starting line of a silica-gel coated micro-slide, about 0.5 cm beyond the lower edge of the slide, and along 2/3 of the slides width, so that a continuous line of applied lipids, about 1 cm long will form. Let the solvent evaporate before repeatedly spotting. Mark the plates on upper right corner so as to identify the sample.
C. Running and developing of chromatograms (proper separation process and visualisation of separated spots) Method: Insert the slides with the applied lipids in the respective separation chamber (N and P), close the jars tightly and allow the solvent to ascend to about 0.3 cm from the top edge. (Caution! Dont let the solvent run off the plate). After the solvent has reached the desired height, remove the plates from the jars and place them horizontally onto a sheet of filter paper, let the solvent evaporate in the open air or in a fume hood, and when dry, place the plates into an iodine containing chamber. The lipid spots will acquire a yellow-brown colour. Circumscribe the spots by means of a thin needle (be careful not to destroy the layer, it is easily broken), and record an image of these chromatograms.
SERUM EGG-YOLK
N P N P
Try to identify the individual lipids on the basis of the given R f -values. (R f -values for neutral lipids separated by means of adsorption TLC with hexane : ethyl-ether : acetic acid are: hydrocarbons and waxes: 0.9-1.0; sterol esters: 0.9; TAG: 0.3-0.4; FFA: 0.18; free sterols: 0.10; DAG: 0.08; MAG 0.0; polar lipids 0.0) (R f -values for phospholipids separated by means of partition TLC with chloroform : methanol : water: cerebrosides: 0.7-0.76; phosphatidic acid: 0.74; cardiolipin: 0.71; phosphatidyl- ethanolamine: 0.62; sphingomyelin: 0.16; phosphatidylserine: 0.15; lyso-compounds: <0.1) Questions: Compare the lipid spectra from the egg-yolk with those from plasma and comment on the differences. Present the normal plasma lipid composition for adults. Which of these lipids are subject to wide diurnal variations? What intra-vascular process enables to utilise the circulating TAG as fuel sources by peripheral tissues? Present by means of appropriate formulas, the reaction which is responsible for the fact that about 75% of the total plasma cholesterol is in the esterified form?
SEMINAR X Metabolism of fatty acids 1. Biosynthesis of FA. Cytosolic pathway for de novo synthesis of saturated FA: a. substrates, enzymes and cofactor requirements for the synthesis of priming units (acetyl-CoA carboxylase) b. FA synthase complex and sequence of reaction catalysed by this enzyme complex c. sources of acetyl-CoA and NADPH d. elongation of the FA chain (microsomal and mitochondrial) e. desaturation of the FA chain f. biosynthesis of hydroxylated FA g. regulation of lipogenesis: nutritional state, regulation of key enzyme activity (acetyl-CoA carboxylase, pyruvate dehydrogenase), hormonal regulation.
2. Degradation of FA: a. -oxidation of FA: activation of FA, formation of acyl-CoA, transport of FA into mitochondria, the site of -oxidation (enzyme and cofactor requirements); individual steps of -oxidation (enzymes and cofactors); -oxidation of unsaturated FA; energy balance of -oxidation b. other oxidative pathways: - and -oxidation of FA, peroxisomal oxidation of FA; oxidation of FA and thermogenesis, metabolism of brown adipose tissue c. ketogenesis (under physiological and pathological conditions): ketone bodies as the immediate fuel for extrahepatic tissues under conditions of glucose deficiency; reactions involved in the utilisation of ketone bodies in extrahepatic tissues; regulation of ketogenesis; ketoacidosis as a result of a metabolic imbalance between ketogenesis and utilisation capacity.
3. Metabolism of unsaturated FA: a. eicosanoids: cyclooxygenase pathway: prostaglandins, prostacyclins and tromboxanes (biosynthesis, degradation and function); lipoxygenase pathway: leukotrines (biosynthesis, degradation and function)
4. Clinical correlations: a. genetic deficiencies in carnitine transport or carnitine palmitoyltransferase b. genetic deficiencies in the acyl-CoA dehydrogenases c. Refsums disease d. diabetic ketoacidosis
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 187-208 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 184-204 Stryer L. Biochemistry 6 th edition pp. 617-648 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 668-675, 680-691, 730-737 SEMINAR XI Biosynthesis and degradation of lipids 1. Metabolism of triacylglycerols (TAG): a. degradation: main sites of TAG degradation (lipolysis): digestive tract, blood plasma and adipose tissue. Regulatory mechanisms controlling the rate of TAG lipolysis b. biosynthesis: main sites and routes of TAG biosynthesis: adipose tissue, liver, intestine. Regulatory mechanisms controlling the rate of TAG synthesis
2. Metabolism and biological role of compound lipids: a. biosynthesis of phosphoglycerides: phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidylglycerols, plasmalogens (syn- thesis de novo and remodelling routes) b. biosynthesis of sphingomyelin c. degradation of phospholipids: role of various phospholipases and role of degradation products (release of polyunsaturated FA, DAG, phosphoinositol) d. roles of various phospholipids: lecithin in blood plasma (aiding in the transport of non-polar lipids, substrate for LCAT activity, reaction catalysed by LCAT) specific role of pulmonary phospholipids as surfactants: dipalmitoyl-phosphatidyl- choline as the primary surfactant, routes of biosynthesis (RDS) l-alkyl-2-acetyl-glycerol-3-phosphocholine: the platelet activating factor (route and site of synthesis) specific role of phosphatidylinositol and of other phospholipids in generating second messengers e. biosynthesis and degradation of glycosphingolipids (cerebrosides, sulfatides and gangliosides) f. sphingolipidoses as a failure in degradation of various sphingolipids
3. Clinical correlations: a. obesity
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 209-216 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 205-211, 460-462 Stryer L. Biochemistry 6 th edition pp.732-738 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 663-664, 676-691, 695-706, 720- 729, 1059-1064 SEMINAR XII Interorgan transport of lipids 1. Lipoproteins: composition, properties, synthesis and function.
2. Metabolism of chylomicrons.
3. Metabolism of VLDL.
4. Metabolism of HDL.
5. Transport and uptake of FA.
6. Role of the liver and adipose tissue in the metabolism of TAG.
7. Role of the liver in the disposal of cholesterol.
8. Hypolipoproteinaemias and hyperlipoproteinaemias as inborn metabolic disorders.
Literature: Murray R. K. et al. Harpers Biochemistry 27 th edition pp. 217-229 Murray R. K. et al. Harpers Biochemistry 28 th edition pp. 212-223 Stryer L. Biochemistry 6 th edition pp.742-748 Devlin T. M. Textbook of Biochemistry 6 th edition pp. 665-667